Fellow Conservative,
This week, the House is voting on Nancy Pelosi’s socialist drug pricing scheme. The so-called “Lower Drug Costs Now Act” (H.R. 3) would institute not one, but two different government price controls over our pharmaceutical industry.
Right now, the United States leads the world in pharmaceutical innovation, but Nancy Pelosi wants to change that. H.R. 3 would put us on par with European countries with price control schemes, who already lag behind the U.S. by 40% in research and development.